← FDA Drug Approvals (Drugs@FDA)

LIRAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2025-07-22

Drug application

FDA Application #

ANDA215421

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIRAGLUTIDE

Generic name

LIRAGLUTIDE

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

LUPIN

Manufacturer

Lupin Pharmaceuticals, Inc.

First approval

2025-07-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown